Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax

MeSH terms

• Adult
• Aged
• Aged, 80 and over
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Bridged Bicyclo Compounds, Heterocyclic* / pharmacology
• Bridged Bicyclo Compounds, Heterocyclic* / therapeutic use
• Female
• Humans
• Infections / etiology
• Infections / mortality
• Leukemia, Myeloid, Acute* / drug therapy
• Leukemia, Myeloid, Acute* / mortality
• Male
• Middle Aged
• Neoplasms, Second Primary / drug therapy
• Neoplasms, Second Primary / mortality
• Prognosis
• Sulfonamides* / therapeutic use
• Survival Rate